Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Conmed (CNMD) Income towards Parent Company (2016 - 2026)

Conmed filings provide 17 years of Income towards Parent Company readings, the most recent being $13.8 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 129.09% to $13.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $54.8 million, a 53.81% decrease, with the full-year FY2025 number at $47.1 million, down 64.47% from a year prior.
  • Income towards Parent Company hit $13.8 million in Q1 2026 for Conmed, down from $16.7 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $49.0 million in Q3 2024 to a low of -$168.3 million in Q2 2022.
  • Median Income towards Parent Company over the past 5 years was $16.7 million (2025), compared with a mean of $10.4 million.
  • Biggest five-year swings in Income towards Parent Company: plummeted 1366.3% in 2022 and later skyrocketed 983.51% in 2024.
  • Conmed's Income towards Parent Company stood at $26.6 million in 2022, then grew by 24.4% to $33.1 million in 2023, then grew by 2.07% to $33.8 million in 2024, then tumbled by 50.41% to $16.7 million in 2025, then dropped by 17.39% to $13.8 million in 2026.
  • The last three reported values for Income towards Parent Company were $13.8 million (Q1 2026), $16.7 million (Q4 2025), and $2.9 million (Q3 2025) per Business Quant data.